在医疗行业的风云变幻中，云南白药（Yunnan Baiyao）旗下的云南省医药有限公司，无疑是一颗闪耀的明星。这个拥有超过70年历史的医药流通企业，凭借其卓越的管理和服务体系，已在云南省药品流通市场中牢牢占据领先地位。

Chu, Michael, William C. Kirby, Nancy Hua Dai, and Yuanzhuo Wang. "Yunnan Baiyao: Transforming a Chinese State-Owned Enterprise." Harvard Business School Case 318-078, February 2018. (Revised April ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

000999.SZ China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Aaa Aaa Aaa 75.95 +21.48% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

has renewed its Sales and Procurement Framework Agreement with Yunnan Baiyao for 2025, securing another year of collaboration. The partnership involves the exchange of medicines, medical devices ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...